{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:14:58Z","timestamp":1765484098964},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00467-017-3789-y","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T04:55:29Z","timestamp":1504241729000},"page":"261-267","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cost analysis on the use of rituximab and calcineurin inhibitors in children and adolescents with steroid-dependent nephrotic syndrome"],"prefix":"10.1007","volume":"33","author":[{"given":"Franca","family":"Iorember","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Aviles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Kallash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwatoyin","family":"Bamgbola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"key":"3789_CR1","first-page":"197","volume":"64","author":"J Oh","year":"2012","unstructured":"Oh J, Kemper MJ (2012) Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment. Minerva Pediatr 64:197\u2013203","journal-title":"Minerva Pediatr"},{"key":"3789_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/2042018816641580","volume":"7","author":"O Bamgbola","year":"2016","unstructured":"Bamgbola O (2016) Metabolic consequences of modern immunosuppressive agents in solid organ transplantation. Ther Adv Endocrinol Metab 7:110\u2013127","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3789_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s004670000523","volume":"16","author":"K Latta","year":"2001","unstructured":"Latta K, von Schnakenburg C, Ehrich JH (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271\u2013282","journal-title":"Pediatr Nephrol"},{"key":"3789_CR4","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00467-011-1837-6","volume":"26","author":"ST Esfahani","year":"2011","unstructured":"Esfahani ST, Madani A, Asgharian F, Ataei N, Roohi A, Moghtaderi M, Rahimzadeh P, Moradinejad MH (2011) Clinical course and outcome of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 26:1089\u20131093","journal-title":"Pediatr Nephrol"},{"key":"3789_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00467-010-1717-5","volume":"26","author":"M Husen van","year":"2011","unstructured":"van Husen M, Kemper MJ (2011) New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 26:881\u2013892","journal-title":"Pediatr Nephrol"},{"key":"3789_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00467-009-1356-x","volume":"25","author":"VR Mello de","year":"2010","unstructured":"de Mello VR, Rodrigues MT, Mastrocinque TH, Martins SP, de Andrade OV, Guidoni EB, Scheffer DK, Martini Filho D, Toporovski J, Benini V (2010) Mycophenolate mofetil in children with steroid\/cyclophosphamide-resistant nephrotic syndrome. Pediatr Nephrol 25:453\u2013460","journal-title":"Pediatr Nephrol"},{"key":"3789_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5301\/JN.2011.6327","volume":"24","author":"TT Gargah","year":"2011","unstructured":"Gargah TT, Lakhoua MR (2011) Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome. J Nephrol 24:203\u2013207","journal-title":"J Nephrol"},{"key":"3789_CR8","first-page":"CD003594","volume":"10","author":"EM Hodson","year":"2016","unstructured":"Hodson EM, Wong SC, Willis NS, Craig JC (2016) Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst Rev 10:CD003594","journal-title":"Cochrane Database Syst Rev"},{"key":"3789_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/ndt\/gfh766","volume":"20","author":"I Mahmoud","year":"2005","unstructured":"Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M (2005) Single-center experience with cyclosporine in 106 children with idiopathic focal segmental glomerulosclerosis. Nephrol Dial Transplant 20:735\u2013742","journal-title":"Nephrol Dial Transplant"},{"key":"3789_CR10","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/ndt\/gfi059","volume":"20","author":"A El-Husseini","year":"2005","unstructured":"El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M (2005) Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-center experience. Nephrol Dial Transplant 20:2433\u20132438","journal-title":"Nephrol Dial Transplant"},{"key":"3789_CR11","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.2215\/CJN.00110112","volume":"7","author":"K Ishikura","year":"2012","unstructured":"Ishikura K, Yoshikawa N, Nakazato H, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ito S, Yata N, Ando T, Honda M, Japanese Study Group of Renal Disease in Children (2012) Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children. Clin J Am Soc Nephrol 7:1576\u20131583","journal-title":"Clin J Am Soc Nephrol"},{"key":"3789_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/jclinpath-2011-200005","volume":"64","author":"JH Kim","year":"2011","unstructured":"Kim JH, Park SJ, Yoon SJ, Lim BJ, Jeong HJ, Lee JS, Kim PK, Shin JI (2011) Predictive factors for cyclosporine-associated nephrotoxicity in children with minimal change nephrotic syndrome. J Clin Pathol 64:516\u2013519","journal-title":"J Clin Pathol"},{"key":"3789_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF00856511","volume":"8","author":"SA Hulton","year":"1994","unstructured":"Hulton SA, Neuhaus TJ, Dillon MJ, Barratt TM (1994) Long-term cyclosporine a treatment of minimal-change nephrotic syndrome of childhood. Pediatr Nephrol 8:401\u2013403","journal-title":"Pediatr Nephrol"},{"key":"3789_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","volume":"24","author":"K Kamei","year":"2009","unstructured":"Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M, Saito M, Yoneko M, Iijima K (2009) Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol 24:1321\u20131328","journal-title":"Pediatr Nephrol"},{"key":"3789_CR15","doi-asserted-by":"publisher","first-page":"8219","DOI":"10.1038\/srep08219","volume":"5","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Liao G, Li Y, Zhou S, Zoua H (2015) The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: a meta-analysis. Sci Rep 5:8219. \n                    https:\/\/doi.org\/10.1038\/srep08219","journal-title":"Sci Rep"},{"key":"3789_CR16","doi-asserted-by":"publisher","unstructured":"Maratea D, Bettio M, Corti MG, Montini G, Venturini F (2016) The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective. Ital J Pediatr 42:63. \n                    https:\/\/doi.org\/10.1186\/s13052-016-0271-6","DOI":"10.1186\/s13052-016-0271-6"},{"key":"3789_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1681\/ASN.2013030251","volume":"25","author":"P Ruggenenti","year":"2014","unstructured":"Ruggenenti P, Ruggiero B, Cravedi P, Vivarelli M, Massella L, Maras\u00e0 M, Chianca A, Rubis N, Ene-Iordache B, Rudnicki M, Pollastro RM, Capasso G, Pisani A, Pennesi M, Emma F, Remuzzi G (2014) Rituximab in Nephrotic syndrome of steroid-dependent or frequently relapsing minimal change disease or focal segmental Glomerulosclerosis (NEMO) study group. Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J Am Soc Nephrol 25:850\u2013863","journal-title":"J Am Soc Nephrol"},{"key":"3789_CR18","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y (2014) Rituximab for childhood-onset refractory Nephrotic syndrome (RCRNS) study group. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter, double-blind, randomized, placebo-controlled trial. Lancet 384:1273\u20131281","journal-title":"Lancet"},{"key":"3789_CR19","doi-asserted-by":"publisher","unstructured":"Takura T, Takei T, Nitta K (2017) Cost-effectiveness of administering Rituximab for steroid-dependent Nephrotic syndrome and frequently relapsing Nephrotic syndrome: a preliminary study in Japan. Sci Rep 7:46036. \n                    https:\/\/doi.org\/10.1038\/srep46036","DOI":"10.1038\/srep46036"},{"key":"3789_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/17843286.2016.1208955","volume":"72","author":"I Horebeek Van","year":"2017","unstructured":"Van Horebeek I, Knops N, Van Dyck M, Levtchenko E, Mekahli D (2017) Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature. Acta Clin Belg 72:147\u2013155","journal-title":"Acta Clin Belg"},{"key":"3789_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3892\/br.2016.711","volume":"5","author":"XL Niu","year":"2016","unstructured":"Niu XL, Hao S, Wang P, Zhang W, Guo GM, Wu Y, Kuang XY, Zhu GH, Huang WY (2016) Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome. Biomed Rep 5:237\u2013242","journal-title":"Biomed Rep"},{"key":"3789_CR22","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.2215\/CJN.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A (2010) Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5:2207\u20132212","journal-title":"Clin J Am Soc Nephrol"},{"key":"3789_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4103\/1319-2442.152420","volume":"26","author":"K Mishra","year":"2015","unstructured":"Mishra K, Ramachandran S, Firdaus S, Rath B (2015) The impact of pediatric nephrotic syndrome on parents' health-related quality of life and family functioning: an assessment made by the PedsQL 4.0 family impact module. Saudi J Kidney Dis Transpl 26:285\u2013292","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"3789_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1517\/14712598.2015.1045870","volume":"15","author":"D Santoro","year":"2015","unstructured":"Santoro D, Pellican\u00f2 V, Visconti L, Trifir\u00f2 G, Cernaro V, Buemi M (2015) Monoclonal antibodies for renal diseases: current concepts and ongoing treatments. Expert Opin Biol Ther 15:1119\u20131143","journal-title":"Expert Opin Biol Ther"},{"key":"3789_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000368589","volume":"128","author":"P Cravedi","year":"2014","unstructured":"Cravedi P, Remuzzi G, Ruggenenti P (2014) Rituximab in primary membranous nephropathy: first-line therapy, why not? Nephron Clin Pract 128:261\u2013269","journal-title":"Nephron Clin Pract"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3789-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3789-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3789-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T14:14:36Z","timestamp":1552659276000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3789-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["3789"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3789-y","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]},"assertion":[{"value":"17 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}